BRÈVE

sur Piramal Pharma Solutions

Piramal Pharma Solutions Achieves High Net Promoter Score

Piramal Pharma Solutions, a key player in the Contract Development and Manufacturing Organization sector, has recently attained a remarkable Net Promoter Score (NPS) of 55. This score is significantly higher than the industry norm, highlighting the company’s commitment to stakeholder focus and operational excellence. The survey and score were validated by DNV, an independent assurance expert, ensuring credibility.

NPS is an essential metric for assessing customer loyalty, indicating how likely customers are to recommend the company’s services. Piramal Pharma's high score reflects their dedication to going beyond mere customer satisfaction, aiming for customer delight through strategic engagements guided by customer insights.

This achievement reinforces Piramal Pharma Solutions’ leadership role among competitor CDMOs, emphasizing their continuous improvement in service offerings and process optimization to deliver high value to stakeholders globally.

R. H.

Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Piramal Pharma Solutions